Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01730105 · ClinicalTrials.gov registry record
Chronic Cold Exposure and Energy Metabolism in Humans
A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 7
- Enrollment target
NCT01730105 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 7 participants.
The verdict
NCT01730105 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Background: \- Researchers are studying how metabolism and hormone levels change in response to mild changes in environmental temperature. Changes in metabolism may lessen with time because of hormonal adaptations. If this increase in metabolism continues for a longer period, mild cold exposure may cause weight loss. It is unclear whether exposure to a warmer temperature may cause opposite changes in metabolism. Researchers want to see if longer exposure (1 month) to different temperatures can affect how the body uses energy. Objectives: \- To test changes in energy metabolism in response to different room temperatures. Eligibility: \- Healthy men between 18 and 40 years of age. Design: * The entire study will last for 4 months. It will involve a screening visit and a 4-month inpatient stay at the National Institutes of Health Clinical Center. The inpatient stay will be in a private room at the Metabolic Clinical Research unit. Study participants will be required to stay in the Metabolic Clinical Research unit during the night, but are free to leave during the day. * At the screening visit, participants will have a physical exam and medical history. Blood samples will be collected. A heart function test and diet questionnaire will also be given. * During the first month, the temperature of the private room will be set at to 75.2 degrees F. This will allow the body to become used to the testing environment. * During the second month, the temperature will be set to either a cool (66.2 degrees F) or a warm (80.6 degrees F) temperature. * During the third month, the temperature will return to 75.2 degrees F. * During the fourth month, the temperature will be altered to the opposite temperature to the one set in the second month. * Throughout stay, participants will have daily temperature monitoring and will keep a food diary. Once a week, they will collect all of their urine for 24 hours. Once a month, they will spend 24 hours in a metabolic suite to study their
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-11-17 |
| Est. Completion | 2018-05-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01730105
The ClinicalTrials.gov registry entry for NCT01730105 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01730105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01730105 about?
NCT01730105 is a clinical study titled "Chronic Cold Exposure and Energy Metabolism in Humans". Background: \- Researchers are studying how metabolism and hormone levels change in response to mild changes in environmental temperature. Changes in metabolism may lessen with time because of hormonal adaptations. If this increase in metabolism continues for a longer period, mild cold exposure may...
What is the current status of trial NCT01730105?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2012-11-17. Estimated completion is 2018-05-10.
Who is sponsoring clinical trial NCT01730105?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.